Why Editas Medicine’s Shares Fell 28.9% This Week
The company’s progress for its lead therapy has been slow.
Mindfully Curated
The company’s progress for its lead therapy has been slow.
A mass-market vehicle may be coming in the near future.
These two companies have been southbound lately.
Researchers have identified how the brain triages emotions during dream sleep to consolidate the storage of positive emotions while dampening the consolidation of negative ones. The work expands the importance of sleep in mental health and opens new wa…
In early research, the oral medication zanubrutinib was found to help most patients with a slow-growing type of cancer known as marginal zone lymphoma.
The transgenic papaya ‘SunUp’ was developed in the 1990s and was widely publicized because of its ability to resist the papaya ringspot virus. A new study has now identified the genomic changes involved and how they influence the transgenic plants.
Researchers have untangled the intricate physics and neural controls that enable dragonflies to right themselves while they’re falling.
Patients prescribed antibiotics in hospital are more likely to get fungal infections because of disruption to the immune system in the gut, according to a new study.
The effect of variability on learning is recognized in many fields: learning is harder when input is variable, but variability leads to better generalization of the knowledge we learned. In this review, researchers bring together over 150 studies on va…
Despite a world that is still in a pandemic, Disney’s parks are on pace to beat their 2019 performance.
The payments companies all generated solid results for the quarter ending March 31.
The fast-growing Internet of Things market is helping this company expand revenues at an impressive rate.
Two tweets by Elon Musk sent the stock falling.
After a rough few quarters, the company expects revenue and profits to accelerate over the rest of the year.
If the market continues to fall, you’re going to have a lot more buying power for your C-note.
The medical apparel company’s share price is now down 64% across 2022’s trading.
Life-like organ replicas — so-called 3D organoids — are a good way to research disease processes. A team has now presented a kind of blueprint for such a model of the cervix.
A single hormone appears to coordinate the lifespan extension produced by a low-protein diet. Low-protein diets produce beneficial metabolic effects in aged mice, improving metabolic health, reducing frailty, and extending lifespan. These beneficial ef…
For our sake and the environment, there is a considerable amount of research into the reduction of plastic for many and various applications. Researchers have now found a way to imbue relatively sustainable paper materials with some of the useful prope…
Because of this stock market crash, some wonderful stocks are super cheap in 2022. Here’s a mini-portfolio of innovative companies trading under $10 a share right now.